LANSING, Mich. — Neogen Corporation (“Neogen”) (NASDAQ: NEOG) announced that, at the special meeting of Neogen shareholders held today, Neogen shareholders voted to approve all proposals required in connection with the pending combination of the food safety business of 3M Company (“3M”) (NYSE: MMM) with Neogen, including the issuance of shares of Neogen common stock pursuant […]
LGC’s latest environmental, social and governance (ESG) report is now available, covering the period of 1 April 2021 – 31 March 2022. This is LGC’s second ESG report using the Global Reporting Initiative (GRI) Standards, the most widely used sustainability reporting framework globally. Euan O’Sullivan, LGC’s President and Chief Executive Officer, explained, “Last year, I shared […]
Researchers are invited to apply to receive DNA that has been synthesised using Evonetix’s platform Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the opening of its early access program for semiconductor synthesised DNA. Evonetix’s DNA synthesis capability brings together patented semiconductor chip design and proprietary, thermally controlled […]
New partnership will use the power of high-throughput sequencing to measure and understand marine life in our oceans at a rate that eclipses traditional research methods SAN DIEGO — Minderoo Foundation and Illumina, Inc. (NASDAQ: ILMN), today announced a 40 million Australian dollar (US $27.8 million) partnership that will leverage the power of genomics to accelerate scientific […]
Session will showcase the rapidly growing use and groundbreaking impact of clinical genomics in oncology SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that it will feature Dr. Karen Knudsen, CEO of the American Cancer Society, at its inaugural Illumina Genomics Forum (IGF) on October 1. […]
This approval marks the Oncomine Dx Target Test’s 8th CDx therapy selection indication CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients whose tumors have a HER2 (ERBB2) activating mutations (SNVs & Exon 20 Insertion) in […]
New deal strengthens Congenica’s presence in India CAMBRIDGE, England — Congenica, a digital health company that enables precision medicine through its world-leading diagnostic decision support platform for genomic data, today announces a partnership with Avesthagen, a biotechnology major that specialises in predictive, preventive and personalised healthcare through the convergence of food, pharma and population genetics. […]
San Diego, CA – Proteintech Group today announces that it has established a new subsidiary company, Proteintech Genomics, based out of the thriving life sciences hub of San Diego, California. Proteintech Genomics is building out fully optimized and highly multiplexed proteomic assays to enhance multiomic capabilities across a number of spatial and single cell analysis […]
QIAseq Targeted DNA Pro Panels halve library preparation time for sequencing samples New low-input kit for RNA sequencing further expands QIAGEN’s universal NGS portfolio and reduces disposable plastics use by 90% Four million samples have been processed by growing range of QIAseq NGS panels running on any sequencer Hilden, Germany, and Germantown, Maryland — QIAGEN […]
Element Biosciences Inc., developer of the Element AVITI System, a new and disruptive DNA sequencing platform, announced today it will implement no price increases to the entire range of AVITI reagents, including the sequencing kit, the Adept™ and Elevate™ kits. This effort to democratize their technology and make it more broadly available and affordable, will take effect immediately […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
